{"data":{"id":363,"lang":"en","title":"Blood Test Can Predict When Alzheimer's Symptoms Will Start Years in Advance","summary":"New blood test measuring p-tau217 protein can predict Alzheimer's symptom onset within 3-4 years, according to a Nature Medicine study.","category":"science","category_label":"Science","published_at":"2026-02-23T14:01:33Z","updated_at":"2026-02-23T14:01:33Z","url":"https://techtools.cz/tools/news/article/363-blood-test-can-predict-when-alzheimer-s-symptoms-will-start-years-in-advance","api_url":"https://techtools.cz/news-api/v1/articles/363?lang=en","markdown_url":"https://techtools.cz/news-api/v1/articles/363.md?lang=en","image_url":"https://neurosciencenews.com/files/2026/02/alzheimers-symptoms-blood-neuroscience.jpg","word_count":146,"reading_time_minutes":1,"sources":[{"url":"https://www.nature.com/articles/s41591-026-04206-y","domain":"nature.com"},{"url":"https://medicine.washu.edu/news/blood-test-clocks-predict-when-alzheimers-symptoms-will-start/","domain":"medicine.washu.edu"},{"url":"https://neurosciencenews.com/alzheimers-blood-clock-symptoms-30153/","domain":"neurosciencenews.com"}],"translation":{"lang":"cs","id":353,"title":"Krevní test dokáže předpovědět nástup příznaků Alzheimerovy choroby s předstihem několika let","url":"https://techtools.cz/tools/news/clanek/353-krevni-test-dokaze-predpovedet-nastup-priznaku-alzheimerovy-choroby-s","api_url":"https://techtools.cz/news-api/v1/articles/353?lang=cs"},"content":"Researchers at Washington University School of Medicine have developed blood test \"clocks\" that can estimate when a person will begin showing Alzheimer's symptoms, with accuracy within 3 to 4 years. The models measure a protein called p-tau217 in plasma, which rises in a remarkably consistent pattern long before memory loss begins. The study, published in Nature Medicine on February 19, analyzed data from two major long-running Alzheimer's research initiatives.\n\nThe findings reveal a striking age-dependent pattern: a person with elevated p-tau217 at age 60 typically develops symptoms 20 years later, while someone whose levels rise at age 80 shows symptoms only 11 years afterward. Lead researchers Suzanne Schindler and Kellen Petersen say this could transform early intervention strategies.\n\nCurrently, p-tau217 blood tests can help diagnose Alzheimer's in patients already showing cognitive impairment, but are not yet recommended for screening cognitively healthy individuals outside of clinical trials."}}